placeholder image
ACCORD Study Group All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients. 
    Kidney International. 2012
  • Effects of combination lipid therapy in type 2 diabetes mellitus. 
    New England Journal of Medicine. 2010
  • Effects of intensive blood-pressure control in type 2 diabetes mellitus. 
    New England Journal of Medicine. 2010
  • Effects of medical therapies on retinopathy progression in type 2 diabetes. 
    New England Journal of Medicine. 2010
  • Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. 
    American Journal of Cardiology. 2007
  • Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. 
    American Journal of Cardiology. 2007
  • Health-related quality of life and cost-effectiveness components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: rationale and design. 
    American Journal of Cardiology. 2007
  • Recruitment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. 
    American Journal of Cardiology. 2007
  • Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. 
    American Journal of Cardiology. 2007
    • Review
  • Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial [review]. 
    American Journal of Cardiology. 2007
    • Contact
    full name
  • ACCORD Study Group
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration